DK1708679T3 - Farmaceutiske sprayformulering, der omfatter en hydrofluoralkan og en acyleret cyclodextrin - Google Patents
Farmaceutiske sprayformulering, der omfatter en hydrofluoralkan og en acyleret cyclodextrinInfo
- Publication number
- DK1708679T3 DK1708679T3 DK04798662T DK04798662T DK1708679T3 DK 1708679 T3 DK1708679 T3 DK 1708679T3 DK 04798662 T DK04798662 T DK 04798662T DK 04798662 T DK04798662 T DK 04798662T DK 1708679 T3 DK1708679 T3 DK 1708679T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrofluoroalkane
- spray formulation
- pharmaceutical spray
- acylated cyclodextrin
- acylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0303179A SE0303179D0 (sv) | 2003-11-26 | 2003-11-26 | Novel compounds |
| PCT/GB2004/004957 WO2005053637A2 (en) | 2003-11-26 | 2004-11-24 | Pharmaceutical spray formulation comprising a hypro fluor alkane amd an acylated cyclodextrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1708679T3 true DK1708679T3 (da) | 2009-02-16 |
Family
ID=29729189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04798662T DK1708679T3 (da) | 2003-11-26 | 2004-11-24 | Farmaceutiske sprayformulering, der omfatter en hydrofluoralkan og en acyleret cyclodextrin |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070104652A1 (de) |
| EP (1) | EP1708679B1 (de) |
| JP (1) | JP4950666B2 (de) |
| KR (1) | KR20060118509A (de) |
| CN (1) | CN100592908C (de) |
| AT (1) | ATE413868T1 (de) |
| AU (1) | AU2004294775B2 (de) |
| BR (1) | BRPI0416992A (de) |
| CA (1) | CA2546441C (de) |
| CY (1) | CY1108753T1 (de) |
| DE (1) | DE602004017783D1 (de) |
| DK (1) | DK1708679T3 (de) |
| ES (1) | ES2314469T3 (de) |
| HK (1) | HK1108390A1 (de) |
| IL (1) | IL175659A (de) |
| MX (1) | MXPA06005643A (de) |
| NO (1) | NO20062969L (de) |
| NZ (1) | NZ547355A (de) |
| PL (1) | PL1708679T3 (de) |
| PT (1) | PT1708679E (de) |
| SE (1) | SE0303179D0 (de) |
| SI (1) | SI1708679T1 (de) |
| WO (1) | WO2005053637A2 (de) |
| ZA (1) | ZA200604330B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006008568A (ja) * | 2004-06-24 | 2006-01-12 | Cyclochem:Kk | ＩｇＥ抗体抑制剤および食品 |
| KR20240127331A (ko) * | 2021-12-28 | 2024-08-22 | 린텍 가부시키가이샤 | 실리콘계 점착제, 점착 시트 및 양면 점착 시트 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| US5654442A (en) * | 1989-11-14 | 1997-08-05 | The Perkin-Elmer Corporation | 4,7-dichlorofluorescein dyes as molecular probes |
| TW249226B (de) * | 1990-04-04 | 1995-06-11 | Aderk Ueno Kk | |
| DE69103503T2 (de) * | 1990-09-28 | 1995-01-05 | Mercian Corp | Adriamycinderivate. |
| FR2692168B1 (fr) * | 1992-06-16 | 1995-03-24 | Centre Nat Rech Scient | Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères. |
| US5916883A (en) * | 1996-11-01 | 1999-06-29 | Poly-Med, Inc. | Acylated cyclodextrin derivatives |
| DE10205087A1 (de) * | 2002-02-07 | 2003-08-21 | Pharmatech Gmbh | Cyclodextrine als Suspensionsstabilisatoren in druckverflüssigten Treibmitteln |
-
2003
- 2003-11-26 SE SE0303179A patent/SE0303179D0/xx unknown
-
2004
- 2004-11-24 PT PT04798662T patent/PT1708679E/pt unknown
- 2004-11-24 DK DK04798662T patent/DK1708679T3/da active
- 2004-11-24 EP EP04798662A patent/EP1708679B1/de not_active Not-in-force
- 2004-11-24 AU AU2004294775A patent/AU2004294775B2/en not_active Ceased
- 2004-11-24 BR BRPI0416992-1A patent/BRPI0416992A/pt not_active IP Right Cessation
- 2004-11-24 JP JP2006540609A patent/JP4950666B2/ja not_active Expired - Fee Related
- 2004-11-24 ES ES04798662T patent/ES2314469T3/es active Active
- 2004-11-24 US US10/580,589 patent/US20070104652A1/en not_active Abandoned
- 2004-11-24 CA CA2546441A patent/CA2546441C/en not_active Expired - Fee Related
- 2004-11-24 WO PCT/GB2004/004957 patent/WO2005053637A2/en active Application Filing
- 2004-11-24 MX MXPA06005643A patent/MXPA06005643A/es active IP Right Grant
- 2004-11-24 KR KR1020067010242A patent/KR20060118509A/ko not_active Application Discontinuation
- 2004-11-24 SI SI200430972T patent/SI1708679T1/sl unknown
- 2004-11-24 AT AT04798662T patent/ATE413868T1/de active
- 2004-11-24 DE DE602004017783T patent/DE602004017783D1/de active Active
- 2004-11-24 CN CN200480040939A patent/CN100592908C/zh not_active Expired - Fee Related
- 2004-11-24 NZ NZ547355A patent/NZ547355A/en not_active IP Right Cessation
- 2004-11-24 PL PL04798662T patent/PL1708679T3/pl unknown
-
2006
- 2006-05-15 IL IL175659A patent/IL175659A/en not_active IP Right Cessation
- 2006-05-25 ZA ZA200604330A patent/ZA200604330B/en unknown
- 2006-06-26 NO NO20062969A patent/NO20062969L/no not_active Application Discontinuation
-
2008
- 2008-03-06 HK HK08102612.6A patent/HK1108390A1/xx not_active IP Right Cessation
-
2009
- 2009-01-19 CY CY20091100063T patent/CY1108753T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004294775A1 (en) | 2005-06-16 |
| NO20062969L (no) | 2006-08-25 |
| AU2004294775B2 (en) | 2007-12-20 |
| KR20060118509A (ko) | 2006-11-23 |
| HK1108390A1 (en) | 2008-05-09 |
| WO2005053637A2 (en) | 2005-06-16 |
| IL175659A (en) | 2010-02-17 |
| DE602004017783D1 (de) | 2008-12-24 |
| US20070104652A1 (en) | 2007-05-10 |
| JP4950666B2 (ja) | 2012-06-13 |
| PL1708679T3 (pl) | 2009-04-30 |
| PT1708679E (pt) | 2008-12-29 |
| CY1108753T1 (el) | 2014-04-09 |
| SI1708679T1 (sl) | 2009-04-30 |
| NZ547355A (en) | 2009-05-31 |
| WO2005053637A3 (en) | 2007-06-28 |
| BRPI0416992A (pt) | 2007-02-06 |
| SE0303179D0 (sv) | 2003-11-26 |
| ZA200604330B (en) | 2007-11-28 |
| MXPA06005643A (es) | 2006-08-17 |
| CN101087600A (zh) | 2007-12-12 |
| EP1708679A2 (de) | 2006-10-11 |
| ES2314469T3 (es) | 2009-03-16 |
| IL175659A0 (en) | 2006-09-05 |
| CN100592908C (zh) | 2010-03-03 |
| CA2546441C (en) | 2011-11-22 |
| ATE413868T1 (de) | 2008-11-15 |
| JP2007515401A (ja) | 2007-06-14 |
| EP1708679B1 (de) | 2008-11-12 |
| CA2546441A1 (en) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
| IL174154A (en) | History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines | |
| CY2016024I2 (el) | ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ | |
| BRPI0509827A (pt) | nanopartìculas pegiladas para transporte de moléculas biologicamente ativas, composição farmacêutica, liofilizato constituindo nanopartìculas pegiladas e processo de preparação de nanopartìculas pegiladas | |
| ATE496064T1 (de) | Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten | |
| DK1319183T3 (da) | Fremgangsmåder og produkter relateret til heparin med lav molekylvægt | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| SI1909843T1 (sl) | Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju | |
| PA8548801A1 (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
| BRPI0407583A (pt) | solução oftálmica lìmpida e estável | |
| CY1110664T1 (el) | Ενδορινικες συνθεσετς | |
| NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
| AU5218001A (en) | Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals | |
| YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
| HK1057336A1 (en) | Pharmaceutical solutions of modafinil compounds | |
| AR058141A1 (es) | Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas | |
| WO2004112771A8 (en) | Pharmaceutical compositions including an antihistamine and a stimulant and use thereof | |
| NO20076120L (no) | Stabile nanopartikkelformuleringer | |
| DK1708679T3 (da) | Farmaceutiske sprayformulering, der omfatter en hydrofluoralkan og en acyleret cyclodextrin | |
| ITBO20020544A1 (it) | Uso di farine vegetali come agenti biotossici ad azione ammendante. | |
| DE50308344D1 (de) | Cyclodextrine als suspensionsstabilisatoren in druckverflüssigten treibmitteln | |
| AU2006272424A8 (en) | Homogemcitabines | |
| DK1200088T3 (da) | Sammensætning indeholdende paracetamol og drotaverin | |
| ITMI20020872A1 (it) | Derivati dell'iperforina loro uso e formulazioni che li contengono | |
| WO2004111088A3 (en) | Angiogenic factor and inhibitors thereof |